Advertisement

Comparison of Outcomes in Patients Having Isolated Transcatheter Aortic Valve Implantation Versus Combined With Preprocedural Percutaneous Coronary Intervention

Published:December 02, 2011DOI:https://doi.org/10.1016/j.amjcard.2011.09.053
      Coronary artery disease negatively affects the outcome of patients undergoing surgical aortic valve replacement and practice guidelines recommend revascularization at time of surgery. In patients undergoing transcatheter aortic valve implantation (TAVI), the impact of preprocedural percutaneous coronary intervention (PCI) on TAVI outcome has not been examined. We aimed in the present study to assess the feasibility and safety of performing PCI before TAVI and to evaluate procedural, 30-day, and 6-month clinical outcomes. We retrospectively analyzed 125 patients who underwent successful TAVI at a single institution and divided them into an isolated TAVI and a PCI + TAVI group. During the study period, a strategy of preprocedural PCI of all significant (>50%) lesions in major epicardial vessels was adopted. Study end points were adjudicated in accordance with the Valve Academic Research Consortium consensus on event definition. All patients were treated with the Medtronic CoreValve prosthesis (n = 55 with PCI + TAVI and n = 70 with isolated TAVI). Thirty-day mortality was 2% versus 6% for patients treated with PCI + TAVI versus isolated TAVI, respectively (p = 0.27). Neither periprocedural nor spontaneous myocardial infarction occurred in either group. Rates of 30-day stroke, major bleeding, major vascular complications, and the Valve Academic Research Consortium–defined combined safety end point (11% vs 13%, p = 0.74) did not differ between the 2 groups. Patients' symptoms significantly improved in the first month after TAVI, and extent of improvement did not differ between groups. Adverse events at 6 months were comparable. In conclusion, PCI before TAVI appears feasible and safe. Based on these early results revascularization should become an important consideration in patients with coronary artery disease undergoing TAVI.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Thomas M.
        • Schymik G.
        • Walther T.
        • Himbert D.
        • Lefèvre T.
        • Treede H.
        • Eggebrecht H.
        • Rubino P.
        • Michev I.
        • Lange R.
        • Anderson W.N.
        • Wendler O.
        Thirty-day results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve.
        Circulation. 2010; 122: 62-69
        • Leon M.B.
        • Smith C.R.
        • Mack M.
        • Miller D.C.
        • Moses J.W.
        • Svensson L.G.
        • Tuzcu E.M.
        • Webb J.G.
        • Fontana G.P.
        • Makkar R.R.
        • Brown D.L.
        • Block P.C.
        • Guyton R.A.
        • Pichard A.D.
        • Bavaria J.E.
        • Herrmann H.C.
        • Douglas P.S.
        • Petersen J.L.
        • Akin J.J.
        • Anderson W.N.
        • Wang D.
        • Pocock S.
        • PARTNER Trial Investigators
        Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.
        N Engl J Med. 2010; 363: 1597-1607
        • Grube E.
        • Schuler G.
        • Buellesfeld L.
        • Gerckens U.
        • Linke A.
        • Wenaweser P.
        • Sauren B.
        • Mohr F.W.
        • Walther T.
        • Zickmann B.
        • Iversen S.
        • Felderhoff T.
        • Cartier R.
        • Bonan R.
        Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome.
        J Am Coll Cardiol. 2007; 50: 69-76
        • Leon M.B.
        • Piazza N.
        • Nikolsky E.
        • Blackstone E.H.
        • Cutlip D.E.
        • Kappetein A.P.
        • Krucoff M.W.
        • Mack M.
        • Mehran R.
        • Miller C.
        • Morel M.A.
        • Petersen J.
        • Popma J.J.
        • Takkenberg J.J.
        • Vahanian A.
        • van Es G.A.
        • Vranckx P.
        • Webb J.G.
        • Windecker S.
        • Serruys P.W.
        Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium.
        J Am Coll Cardiol. 2011; 57: 253-269
        • Lund O.
        • Nielsen T.T.
        • Pilegaard H.K.
        • Magnussen K.
        • Knudsen M.A.
        The influence of coronary artery disease and bypass grafting on early and late survival after valve replacement for aortic stenosis.
        J Thorac Cardiovasc Surg. 1990; 100: 327-337
        • Iung B.
        • Drissi M.F.
        • Michel P.L.
        • de Pamphilis O.
        • Tsezana R.
        • Cormier B.
        • Vahanian A.
        • Acar J.
        Prognosis of valve replacement for aortic stenosis with or without coexisting coronary heart disease: a comparative study.
        J Heart Valve Dis. 1993; 2: 430-439
        • Edwards F.H.
        • Peterson E.D.
        • Coombs L.P.
        • DeLong E.R.
        • Jamieson W.R.
        • Shroyer A.L.W.
        • Grover F.L.
        Prediction of operative mortality after valve replacement surgery.
        J Am Coll Cardiol. 2001; 37: 885-892
        • Wijns W.
        • Kolh P.
        • Danchin N.
        • Di Mario C.
        • Falk V.
        • Folliguet T.
        • Garg S.
        • Huber K.
        • James S.
        • Knuuti J.
        • Lopez-Sendon J.
        • Marco J.
        • Menicanti L.
        • Ostojic M.
        • Piepoli M.F.
        • Pirlet C.
        • Pomar J.L.
        • Reifart N.
        • Ribichini F.L.
        • Schalij M.J.
        • Sergeant P.
        • Serruys P.W.
        • Silber S.
        • Sousa Uva M.
        • Taggart D.
        • Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
        • European Association for Percutaneous Cardiovascular Interventions (EAPCI)
        Guidelines on myocardial revascularization.
        Eur Heart J. 2010; 31: 2501-2555
        • Dewey T.M.
        • Brown D.L.
        • Herbert M.A.
        • Culica D.
        • Smith C.R.
        • Leon M.B.
        • Svensson L.G.
        • Tuzcu M.
        • Webb J.G.
        • Cribier A.
        • Mack M.J.
        Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation.
        Ann Thorac Surg. 2010; 89: 758-767
        • Califf R.M.
        • Phillips III, H.R.
        • Hindman M.C.
        • Mark D.B.
        • Lee K.L.
        • Behar V.S.
        • Johnson R.A.
        • Pryor D.B.
        • Rosati R.A.
        • Wagner G.S.
        Prognostic value of a coronary artery jeopardy score.
        J Am Coll Cardiol. 1985; 5: 1055-1063
        • Masson J.B.
        • Lee M.
        • Boone R.H.
        • Al Ali A.
        • Al Bugami S.
        • Hamburger J.
        • John Mancini G.B.
        • Ye J.
        • Cheung A.
        • Humphries K.H.
        • Wood D.
        • Nietlispach F.
        • Webb J.G.
        Impact of coronary artery disease on outcomes after transcatheter aortic valve implantation.
        Catheter Cardiovasc Interv. 2010; 76: 165-173
        • Smith C.R.
        • Leon M.B.
        • Mack M.J.
        • Miller D.C.
        • Moses J.W.
        • Svensson L.G.
        • Tuzcu E.M.
        • Webb J.G.
        • Fontana G.P.
        • Makkar R.R.
        • Williams M.
        • Dewey T.
        • Kapadia S.
        • Babaliaros V.
        • Thourani V.H.
        • Corso P.
        • Pichard A.D.
        • Bavaria J.E.
        • Herrmann H.C.
        • Akin J.J.
        • Anderson W.N.
        • Wang D.
        • Pocock S.J.
        • PARTNER Trial Investigators
        Transcatheter versus surgical aortic-valve replacement in high-risk patients.
        N Engl J Med. 2011; 364: 2187-2198
        • Conradi L.
        • Seiffert M.
        • Franzen O.
        • Baldus S.
        • Schirmer J.
        • Meinertz T.
        • Reichenspurner H.
        • Treede H.
        First experience with transcatheter aortic valve implantation and concomitant percutaneous coronary intervention.
        Clin Res Cardiol. 2011; 100: 311-316
        • Mostafa A.E.
        • Geist V.
        • Abdel-Wahab M.
        Ad-hoc percutaneous coronary intervention and transcatheter aortic valve implantation as a combined transfemoral procedure.
        J Invasive Cardiol. 2011; 23: E102-E105